Abstract
Cardiomyocytes are a stable cell population with only limited potential for renewal after injury. Tissue regeneration may be due to infiltration of stem cells, which differentiate into cardiomyocytes. We have analysed the influx of stem cells in the heart of patients who received either a gender-mismatched BMT (male donor to female recipient) or a gender-mismatched cardiac transplant (HTX; female donor to male recipient). The proportion of infiltrating cells was determined by Y-chromosome in situ hybridization combined with immunohistochemical cell characterization. In BM transplanted patients and in cardiac allotransplant recipients, cardiomyocytes of apparent BM origin were detected. The proportions were similar in both groups and amounted up to 1% of all cardiomyocytes. The number of stem cell-derived cardiomyocytes did not alter significantly in time, but were relatively high in cases where large numbers of BM-derived Y-chromosome-positive infiltrating inflammatory cells were present. The number of Y-chromosome-positive endothelial cells was small and present only in small blood vessels. The number of BM-derived cardiomyocytes in both BMT and HTX is not significantly different between the two types of transplantation and is at most 1%.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schwartz Y, Kornowski R . Progenitor and embryonic stem cell transplantation of myocardial angiogenesis and functional restoration. Eur Heart J 2003; 24: 404–411.
Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750–1757.
Nadal-Ginard B, Katsura J, Leri A, Anversa P . Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003; 92: 139–150.
Orlic D, Hill JM, Arai AE . Stem cells for myocardial regeneration. Circ Res 2002; 91: 1092–1102.
Mummery C, Ward-Van Oostwaard D, Doevedans P, Spijker R, van den Brink S, Hassink R et al. Differentiation of human embryonic stem cells to cardiomyocytes. Role of co-culture with visceral endoderm like cells. Circulation 2003; 107: 2733–2740.
Hassink RJ, Brutel de la Riviere A, Mummery CL, Doevendans PA . Transplantation of cells for cardiac repair. J Am Coll Cardiol 2003; 41: 711–717.
Mangi AA, Noiseaux N, Kong D, He H, Rezvani M, Ingwall JS et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infracted hearts. Nat Med 2003; 9: 1195–1201.
Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005; 433: 647–653.
Murry CE, Soonpas MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664–668.
Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC . Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668–673.
He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A et al. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant 2005; 24: 1940–1949.
Fukuhara S, Tomita S, Nakatani T, Yutani C, Kitamura S . Endogenous bone marrow derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. J Heart Lung Transplant 2005; 24: 67–72.
Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA et al. Adult bone marrow-derived cells for cardiac repair. Arch Intern Med 2007; 167: 989–997.
Dawn B, Bolli R . Bone marrow for cardiac repair: the importance of characterizing the phenotype and function of injected cells. Eur Heart J 2007; 28: 651–652.
Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R et al. Cardiac stem cells deliverd intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 2005; 102: 3766–3771.
Frangioni JV, Hajjar J . In vivo tracking of stem cells for clinical trails in cardiovascular disease. Circulation 2004; 110: 3378–3383.
Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5–15.
Deb S, Wang K, Skelding KA, Miller D, Simper D, Caplice NM . Bone marrow derived cardiomyocytes are present in adult human heart. A study of gender-mismatched bone marrow transplantation patients. Circulation 2003; 107: 1247–1249.
Müller P, Pfeiffer P, Koglin J, Schäfers HJ, Seeland U, Janzen I et al. Cardiomyocytes of non-cardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002; 106: 31–35.
Höchst-Zeisberg E, Kahnert H, Guan K, Wulf G, Hemmerlein B, Schlott T et al. Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur Heart J 2004; 25: 749–758.
Johnson KL, Zhen DK, Bianchi DW . The use of fluorescence in situ hybridization (FISH) on paraffin embedded tissue sections for the study of microchimerism. Biotechniques 2000; 29: 1220–1224.
Van Hoffen E, Van Wichen DF, Stuij I, de Jonge N, Klöpping C, Lahpor J et al. In situ expression of cytokines in human heart allografts. Am J Pathol 1996; 149: 1991–2003.
Cooke HJ, Schmidtke J, Gosden JR . Characterisation of a human Y chromosome repeated sequence and related sequences in higher primates. Chromosoma 1982; 87: 491–502.
Fijnheer R, Sanders CJ, Canninga MR, de Weger RA, Verdonck LF . Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant 2003; 32: 345–347.
Van Hoffen E, Van Wichen DF, Leemans JC, Broekhuizen RA, Bruggink AH, de Boer M et al. T cell apoptosis in human heart allografts. Association with lack of co-stimulation. Am J Pathol 1998; 153: 1813–1824.
Schuurman HJ, Gmelig Meyling FH, Wijngaard PL, Van der Meulen A, Slootweg PJ, Jambroes G . Lymphocyte status in endomyocardial biopsies and blood after heart transplantation. J Pathol 1989; 159: 197–203.
Minami E, Laflamme MA, Saffitz JE, Murry CE . Extracellular progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 2005; 112: 2951–2958.
Steele A, Jones OY, Gok F, Marikar Y, Steele P, Chamizo W et al. Stem-like cells traffic from heart ex vivo, expand in vitro and can be transplanted in vivo. J Heart Lung Transplant 2005; 24: 1930–1939.
Davies WR, Wang S, Oi K, Bailey KR, Tazelaar HD, Caplice NM et al. Cyclosporine decreases vascular progenitor cell numbers after cardiac transplantation and attenuates progenitor cell growth in vitro. J Heart Lung Transplant 2005; 24: 1868–1877.
Thiele J, Varus E, Wickenhauser C, Kvasnika HM, Lorenzen J, Gramley F et al. Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem cell transplantation in comparison with cardiac allografts. Transplantation 2004; 77: 1902–1905.
Hu HZ, De Jonge N, Doornewaard H, Gmelig-Meyling FH, Tilanus MG, Bosboom K et al. Cytotoxic T-lymphocytes infiltrating the human heart allograft show a restriction in T-cell receptor Vβgene usage: a study on serial biopsy and blood specimens. J Heart Lung Transplant 1994; 13: 1058–1071.
Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia- and cytokine-induced mobilization of bone marrow derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434–438.
Shi Q, Rafii S, Hong-De Wu M, Wijelath ES, Yu C, Ishida A et al. Evidence for circulating bone marrow derived endothelial cells. Blood 1998; 92: 362–367.
Jiang S, Walker L, Afentoulis M, Anderson DA, Jouron-Mills L, Corless CL et al. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci USA 2004; 101: 16891–16896.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Weger, R., Verbrugge, I., Bruggink, A. et al. Stem cell-derived cardiomyocytes after bone marrow and heart transplantation. Bone Marrow Transplant 41, 563–569 (2008). https://doi.org/10.1038/sj.bmt.1705939
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705939
Keywords
This article is cited by
-
Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
Journal of Cardiovascular Translational Research (2015)
-
A novel role for bioactive lipids in stem cell mobilization during cardiac ischemia
Journal of Thrombosis and Thrombolysis (2014)
-
CD45-positive cells are not an essential component in cardiosphere formation
Cell and Tissue Research (2013)
-
Directions of Migration of Bone Marrow Mononuclears after Intracoronary Transventricular Injection
Bulletin of Experimental Biology and Medicine (2009)